Abstract: Inotropic agents are commonly used in the treatment of decompensated heart failure, but there is still no guidance on how to choose and apply them in patients with chronic kidney disease (CKD). Based on evidence-based medicine, this paper introduces the pharmacological effects of different kinds of inotropic agents and evaluated the benefits and risks of them in the treatment decompensated heart failure in CKD patients. This papers aim is to provide reference for clinicians in rational application of inotropic agents. 

Key words:  Inotropic agents, Chronic kidney disease, Decompensated heart failure